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Abstract
An abundance of protein structures emerging from structural genomics and the Protein Structure
Initiative (PSI) are not amenable to ready functional assignment because of a lack of sequence and
structural homology to proteins of known function. We describe a high-throughput NMR
methodology (FAST-NMR) to annotate the biological function of novel proteins through the
structural and sequence analysis of protein-ligand interactions. This is based on basic tenets of
biochemistry where proteins with similar functions will have similar active sites and exhibit similar
ligand binding interactions, despite global differences in sequence and structure. Protein-ligand
interactions are determined through a tiered NMR screen using a library composed of compounds
with known biological activity. A rapid co-structure is determined by combining the experimental
identification of the ligand-binding site from NMR chemical shift perturbations with the protein-
ligand docking program AutoDock. Our CPASS (Comparison of Protein Active Site Structures)
software and database is then used to compare this active site with proteins of known function. The
methodology is demonstrated using unannotated protein SAV1430 from Staphylococcus aureus.
Keywords
NMR Screening; High-throughput NMR; Protein-Ligand Binding; Function Assignment;
Hypothetical Protein; SAV1430
Introduction
The availability of the human genome sequence has just begun to provide a wealth of
information on cell biology, development, evolution and physiology that is expanding our
understanding of disease and making beneficial contributions to medicine and human health.
1 Contributing to this expanding knowledge base is the extensive amount of protein structures
emerging from structural genomics and the Protein Structure Initiative (PSI).2
To date, 261 genomes have been completely sequenced with ~1,158 ongoing genome
projects3 where 30,000–90,000 proteins are predicted to be from the human genome alone.1
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Unfortunately, ~60% of recent structures emerging from structural genomics correspond to
folds that provide little insight into function (Fig. 1). The prospect of obtaining functional
information for this extensive collection of hypothetical proteins by traditional biochemical
approaches presents an extremely overwhelming and daunting task.
A fundamental component to our understanding of the biological role of a protein is through
the identification of its functional ligand(s), the identification of its active site or binding site,
and the corresponding determination of a structure for this complex. The active sites of proteins
interact with unique and specific targets, as is well-documented in numerous metabolic and
signaling pathways.4 Promiscuity of binding is inherently detrimental to the overall biological
process. The comparison and prediction of putative ligand binding sites from both structural
and sequence information has proven to be a valuable approach for functional analysis of
proteins.5 Distant evolutionary relationships between enzymes with no sequence similarity
have been identified based on the comparison of conserved active site structures.6 Similarly,
a number of hypothetical proteins determined from structural genomics have had a function
attributed to them by the serendipitous observation of a bound ligand in the resulting structure.
7, 8
We have established the Functional Annotation Screening Technology using NMR
Spectroscopy (FAST-NMR) to provide initial functional information for proteins originating
from structural genomics that lack functional information. By experimentally identifying
ligands that have an associated biological function that bind to hypothetical proteins,
identifying the protein’s active site from this interaction, and determining a corresponding co-
structure of this protein-ligand complex, it is possible to readily infer a potential function for
these novel proteins. Functional annotation will emerge from a combined bioinformatics
approach that incorporates the identity of the functional ligands that bind the protein, the
comparison of the ligand-defined active site identified from FAST-NMR with structures of
protein-ligand complexes for proteins of known function using our CPASS software and
database9, and other readily available methodologies and software.
Analysis of genome sequences for structural genomics target selection have indicated that the
typical protein domain length is ~ 100 residues, where the majority of larger domains fall in
the range of >160–300 residues.10 This indicates that a significant percentage of the proteome
is amenable to analysis by our FAST-NMR methodology11, where further progress in NMR
technology may continue to extend the range of viable protein targets.12 Recent statistical
analysis indicates that ~20–40% of protein structures determined from structural genomics
may be amenable to analysis by NMR13, 14, further supporting the potential general utility of
FAST-NMR. Additional proteins may also become available for analysis when secondary
efforts to optimize conditions are applied outside the practical limits imposed by the high-
throughput structure determination process.15 This paper describes our development of the
FAST-NMR screen and the functional assignment of unannotated protein SAV1430 from
Staphylococcus aureus, a typical target of the Northeast Structural Genomics (NESG)
consortium.
Experimental
Functional Chemical Screening Library
To date, our screening library is composed of 414 compounds with known biological activity
in a total of 113 mixtures comprising 3–4 compounds.16 Reference NMR spectra are collected
for both the individual compounds and the mixtures. These spectra provide NMR assignments
for the compounds, while verifying compound solubility, compatibility, and the presence of
distinct NMR resonances attributed to each compound in the mixture to avoid deconvolution.
Identical chemical shifts, coupling patterns and line-widths between the mixture and individual
Mercier et al. Page 2













NMR spectra verify that no interaction is occurring between the compounds and that the
compounds are equally soluble and stable in the mixture. All the compounds have been
individually weighed, dissolved to a concentration of 20 mM in D2O or D6-DMSO (Sigma
Aldrich, Saint Louis, MO), and stored in standard 2 ml 96-well plates at −80°C.
1D NMR Line-Broadening Experiments
The 1D NMR line-broadening samples consist of 100μM of each compound and 25μM protein
in a 20mM D-Bis-Tris buffer with 11.1μM TMSP as a NMR reference in 100% D2O at pH 7.0
(uncorrected). The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer
equipped with a triple-resonance, Z-axis gradient cryoprobe, a BACS-120 sample changer and
Icon NMR software for automated data collection. 1H NMR spectra were collected with 128
transients at 298 K with solvent presaturation of the residual HDO, a sweep-width of 6009 Hz
and 32K data points and a total acquisition time of 6 minutes. The NMR spectra were processed
automatically using a macro in the ACD/1D NMR manager. The NMR data was Fourier
transformed, zero-filled, phased, and baseline corrected. Each spectrum was referenced with
the TMSP peak set to 0.0 ppm and peak-picked. Compounds were identified as binding to S.
aureus protein SAV1430 by a visual comparison of the free ligand and protein-ligand NMR
spectra. The entire functional chemical library composed of 113 mixtures containing 414
compounds was used in the 1D NMR experiments. Software for the automated analysis of 1D
NMR line broadening data is currently being developed.17
2D 1H-15N HSQC NMR Experiments
22 2D 1H-15N HSQC were collected with 16 transients at 298 K with a sweep-width of 6009Hz
and 1K data points in the direct dimension and 1612Hz and 256 data points in the indirect
dimension for a total acquisition time of 2.5 hours. Each NMR sample consists of 100μM
protein and 400μM compound in a Bis-Tris buffer in 95% H2O, 5%D2O at pH 7.0
(uncorrected). The spectra were processed using NMRPipe on a Linux Workstation. Chemical
shift differences were identified by comparing a reference 2D 1H-15N HSQC spectrum of the
free protein to the spectrum of the compound-protein samples. Chemical shift perturbations
were then mapped onto the surface of the SAV1430 structure (PDB ID: 1PQX) and visualized
using VMD-XPLOR.
Rapid Determination of Protein-Ligand Co-structures
AutoDock was used to obtain co-structures, binding and docking energies for all of the 21
compounds identified to bind SAV1430 from the NMR experiments. Chemical shift changes
identified a consensus binding site comprising residues: I6-P10, T14-K16 and I61-V63. A grid
was manually defined within AutoDock to encompass this experimentally determined ligand-
binding site by adjusting the x, y and z coordinates for the center of the grid box to position
the grid in the binding pocket. The grid size is determined by the number of points in the x, y
and z dimensions and is just visibly large enough to fit the entire ligand.
CPASS Database and Software for Functional Annotation
Comparison of Protein Active site Structures (CPASS) database and software was developed
to aid in the functional annotation of hypothetical proteins by using a protein-ligand co-
structure.9 The CPASS database contains ~26,000 ligand-defined active sites identified from
structures deposited in the PDB. CPASS returns a similarity score (0–100%) and an interactive
3D graphically display of the structural alignment for each active site comparison. The CPASS
software runs on 16-node Beowulf Linux cluster with a simple web-based interface. Each
comparison averages ~40s requiring ~18 hrs. to complete a comparison against the entire
database.
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Bioinformatics Analysis of SAV1430
The SAV1430 PDB structure (http://www.ebi.ac.uk/dali/Interactive.html) was uploaded to the
DALI web server to identify homologous 3D structures. The Dali output contains a list of
aligned structures and corresponding Z-scores, where a higher Z-score indicates a better 3D
fit. Identical structures yield a Z-score of ~30, similar structures a score of ~15, where scores
below 2–3 are generally insignificant and mean the structures are dissimilar. Dali analysis of
SAV1430 only identified structures with Z-scores <3, which included a number of hypothetical
proteins of unknown functions or ferredoxin-like folds.
A web server (http://consurf.tau.ac.il/) interface for the ConSurf software enables a rapid
identification of conserved residues by comparison with structural homologues of known
functions and generating a phylogenic tree. ConSurf outputs an amino acid conservation score
for each residue in the SAV1430 structure, where the highest score represents the highest
evolutionary conserved residue. The scores are normalized such that the average score is zero.
The ConSurf amino acids with high scores were color-coded onto the SAV1430 surface using
VMD-XPLOR.
Rosetta Stone analysis (http://www.igs.cnrs-mrs.fr/FusionDB/main.html) of SAV1430 was
done using FusionDB, a database of bacterial and archael gene fusion events. Submitting the
protein sequence for SAV1430 indicated a gene fusion for proteins SAV1430 and SAV0936
based on hypothetical proteins Q92GV4 and the Q9ZCQ2 in Rickettsia conorii and Rickettsia
proazeki, respectively.18 The quality of the predicted fusion event is measured by the
separation index where a value >0.6 is indicative of a real gene fusion event. A separation
index score of 0.79 was determined for the predicted fusion of genes SAV1430 and SAV0936.
BLAST, FASTA and ClustalW were used with the SAV1430 and SAV0936 sequences to
identify bacterial proteins with homology to both SAV1430 and SAV0936. A prevalence of
hypothetical proteins were identified from the sequence alignments, but a mixture of small
(~80aa) and large (~190aa) NifU-like proteins corresponding to the C-terminal domain of the
multi-domain NifU protein were also observed. Specifically, the sequence alignment of
SAV1430 and SAV0936 against the C-terminal NifU domain from Brucella melitensis yielded
30% and 47% sequence identity, respectively.
Results and Discussion
Description of the FAST-NMR methodology
The overall protocol for the FAST-NMR assay is illustrated in Fig. 2. There are three major
components to the process: (i) identify functional ligands that bind the protein, (ii) use the
ligands to determine protein-ligand co-structures and (iii) use the co-structures with
bioinformatics to infer function. An NMR based screen is used to determine which ligands
from a chemical library bind a hypothetical protein that has been identified from structural
genomics. The structure and NMR assignments for the hypothetical protein are available prior
to initiating the screen. The chemical library that is screened in the FAST-NMR assay is
composed of small molecules with defined functional and biological activity.16 This library
is composed of aminoacids, carbohydrates, co-factors, fatty-acids, hormones, inhibitors,
known drugs, metabolites, neurotransmitters, nucleotides, substrates and vitamins.
The tiered NMR screening assay minimizes valuable resources, such as protein samples and
NMR instrument time, while increasing throughput. To further improve efficiency, ligands are
screened as mixtures of 3–4 compounds based on a statistical analysis to optimize NMR based
screens.19 The mixtures were designed to avoid deconvolution and maximize structural and
functional diversity.
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The first one-dimensional (1D) 1H line-broadening NMR experiment is most suitable for
screening a larger number of compounds using minimal resources while providing preliminary
binding information. A protein-ligand binding interaction is identified by a change in line-
width or complete disappearance of the ligands 1H NMR resonances in the presence of the
protein (Fig. 3a–b). Effectively, a bound ligand acquires the broad NMR line-widths of the
large MW protein.
The second 2D 1H-15N HSQC NMR experiment is only conducted on positive “hits” from the
first NMR experiment, because it is more resource intensive. This experiment monitors NMR
chemical shifts for the backbone amide resonances for each amino acid residue in the protein,
which has been previously assigned during the determination of the protein’s NMR structure.
20 These backbone amide chemical shifts are sensitive to the local environment and change
proportionally to the residues’ proximity to a bound ligand. The residues that incur a chemical
shift change in the presence of the bound ligand can be mapped onto the protein surface to
identify the ligand binding site (Fig. 3d). Non-specific binders will exhibit a random
distribution or complete lack of chemical shift changes.
A protein-ligand co-structure is rapidly generated by combining this experimentally
determined ligand binding site with AutoDock. A grid (Fig. 3d) is used to direct AutoDock to
dock the ligand in this NMR binding site and determine the lowest energy conformation for
the complex. Thus, AutoDock permits an initial structure of the protein-ligand complex to be
calculated in minutes. The AutoDock derived co-structure provides a complete and detailed
description of the ligand binding site. The chemical-shift perturbation mapping of the ligand
binding site is generally incomplete because of chemical shift overlap. Moreover, a lack of a
perturbation in the NH NMR resonances may occur, because the primary interaction between
the ligand and the amino-acid residue is with the side-chain instead of the backbone. Also,
amino-acid residues not in direct contact with the ligand may incur a chemical shift perturbation
because of local structural changes. Additionally, the NMR chemical shift perturbations only
identify residues involved in an interaction with the ligand. The AutoDock co-structure also
identifies relative distances between the ligand and the amino-acid residues.
The Comparison of Protein Active Site Structures (CPASS) database and software enables the
comparison of experimentally identified ligand-binding sites to infer biological function.9
Proteins that exhibit a high similarity in the structural characteristics of their active sites would
suggest a corresponding similarity in function. This is simply a further refinement of generally
accepted paradigms where global sequence and structure homology are routinely used to
annotate function.21 The AutoDock structure of the protein-ligand complex is used to generate
a ligand-defined active site, which comprises any residue in the protein that contains at least
one atom that is ≤ 6Å from any atom in the ligand. The entire PDB database has been similarly
analyzed where each protein that contains a bound ligand had its corresponding ligand-defined
active site extracted as part of the CPASS database. The ligand-defined active site identified
from the FAST-NMR assay using AutoDock is then compared with the CPASS database using
the CPASS software. CPASS iteratively compares the ligand-defined active site with the
database to maximize both the sequence and structural alignments and reports a similarity score
ranging from 0–100%. Protein(s) of known function that exhibit a high similarity with the
unannotated protein’s active site would suggest potential functions for the unknown protein.
It is important to note that the alignment of the ligand-defined active sites does not include the
ligands, but relative distances between the ligands and the active site residues are used in the
CPASS scoring function. The identity of the ligand(s) that bind the unannotated protein in
conjunction with other available bioinformatics tools provide additional insight into possible
functions for the unannotated protein.
Mercier et al. Page 5













Validation of FAST-NMR Using Staphylococcus aureus Protein SAV1430
Staphylococcus aureus (S. aureus) protein SAV1430 is an example of a protein of unknown
biological function that is a typical target of NESG. Dali analysis suggests SAV1430 has a
topology similar to ferredoxin-like folds; however, the Z-score of < 3 is not significant.22 The
only significant sequence homology was to hypothetical proteins. Taken together,
bioinformatic analysis alone failed to assign a reliable function to SAV1430. The NMR
resonance assignments and corresponding solution structure for SAV1430 were determined
by the effort at NESG.23, 24
The 1D NMR line-broadening experiments using our entire functional chemical library
identified 21 compounds that bind SAV430 (Fig. 3a–b). The compounds exhibit similar
structural features that are consistent with binding in an optimized active site for SAV1430
and suggestive of the natural ligand. The compounds are generally similar to O-phospho-L-
tyrosine (pTyr). The structures tend to contain one or more aromatic rings that overlap with
the phenyl ring in pTyr with one or more hydrophilic substituents that either overlaps with the
amino acid or phosphate group in pTyr (e.g. 2-amino-4-methylphenol, nicotinic acid and
acetylsalicylic acid).
These 21 compounds were further evaluated for SAV1430 binding in the second tiered
2D 1H-15N HSQC NMR experiments. Specifically, pTyr was identified as one of the
compounds that exhibited higher chemical shift perturbations through a visual inspection of
histogram plots of the chemical shift perturbations for the 21 compounds (Fig. 3c). Analysis
of the 2D 1H-15N HSQC NMR spectra implies a distinct, consensus binding site that comprises
residues I6-P10, T14-K16 and I61-V63. Based on these NMR results, protein-ligand co-
structures have been generated using AutoDock targeting the identified binding pocket (Fig.
3d–f). This binding site corresponds to a shallow cleft on the SAV1430 surface surrounded by
relatively flat structural features. A GRASP representation of the electropotential surface
indicates that most of the ligand binding site is hydrophobic in nature (Fig. 3e). A small positive
patch (Lys 16) and negative patch (Asp 64) are part of or proximal to the ligand binding site.
The weak ligand binding interactions with SAV1430 in conjunction with the indistinct and
generally flat hydrophobic structural characteristics of the consensus ligand binding site is
strongly suggestive of a protein-protein interaction site.
ConSurf was used to identify residues in the SAV1430 structure that are conserved with
homologous proteins with a known structure. These conserved residues are predicted to be
functionally important to the biological activity of SAV1430 and were mapped onto the
protein’s surface (Fig. 3g). The experimentally determined SAV1430 ligand binding site is
consistent with the functionally conserved residues identified by ConSurf supporting the
biological relevance of this region of SAV1430. Furthermore, the FAST-NMR defined ligand
binding site corresponds to the most prominent structural feature (binding cleft) within the
larger surface area described by ConSurf.
CPASS analysis of the SAV1430-pTyr binding site identified a Src SH2 domain complexed
with a phosphotyrosine containing peptide, along with other SH2 domains, as a significant hit
(37% similarity). Visual comparison of the two ligand binding sites clearly indicates a
similarity in local structure, primarily a flat β-sheet, and sequence composition (Fig. 3i-j). SH2
domains are typically part of multidomain proteins involved in cell signaling and form a
protein-protein complex with a kinase after phosphorylation of a tyrosine.25 Phosphorylation
of Ser, Thr and Tyr are also common mechanisms for regulating protein activity in bacteria.
26, 27 The similarity in the characteristics of the SAV1430 and Src SH2 ligand binding sites
and the fact that SAV1430 binds pTyr further supports the general proposal that SAV1430
functions by forming a protein-protein complex.
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Bioinformatics Analysis of FAST-NMR Results of SAV1430
The NIF (nitrogen fixation), ISC (iron-sulfur cluster) and SUF (sulfur) [Fe-S] cluster assembly
networks are essential for the viability of bacteria.28, 29 The assembly of [Fe-S] clusters is a
complex, poorly understood process involving multiple proteins. [Fe-S] clusters are utilized
in >100 proteins for a variety of functions. NifU is a multi-protein complex within the NIF
[Fe-S] cluster assembly network that is involved in the overall biosynthesis of FeMo-cofactor.
The current viewpoint is that NifU provides a scaffold for the assembly of transient [2Fe–2S]
units for the formation of a [Fe–S] cluster in nitrogenase, an important component of biological
nitrogen fixation. The [Fe-S] assembly scaffold is located in the N-terminus of the NifU
homodimer structure, the central region of the protein contains a permanent [2FE-2S] cluster
and the C-terminus appears to contain a second transient [Fe-S] assembly scaffold. NifU
functions as a homodimer, where a number of proteins have been identified as components of
the FeMo-cofactor biosynthesis pathway. NifU has been shown to form a macromolecular
complex with NifS.30 Also, the identification of two transient [Fe-S] cluster assembly scaffolds
within NifU suggests target specificity between NifU and the other components of the FeMo-
cofactor biosynthesis pathway. The assembly of macromolecular complexes appears to be an
important component of the FeMo-cofactor biosynthesis pathway.
SAV1430 is homologous to the N-terminal domain of the S. cerivisae NIFU protein. Rosetta
Stone analysis reveals that the C-terminal domain of S. cervivsae NIFU is also found in a distant
part of the S. aureus genome as gene SAV0936. This analysis suggests that SAV0936 may be
a binding partner of SAV1430. In order to validate the FAST-NMR active site prediction we
were able to use a homolog of SAV0936, the Staphylococcus epidermidis protein SE063031,
32 (95% identity) to perform in-silico docking experiments. An unbiased model of a SAV1430-
SE0630 complex was generated using Hex (Fig. 3h). Hex determines a protein-protein complex
by identifying complementary binding sites based on surface shape and electrostatic charge
and potential distributions. SE0630 was preferentially docked to SAV1430 in the same binding
site determined by the NMR ligand binding studies. This further supports a protein-protein
binding interaction as part of the biological activity of SAV1430.
SAV0936 exhibits 47% sequence identity with the N-terminal region of the C-terminal NifU
domain (Fig. 4). SAV0936 contains a surface exposed CXXC loop motif that aligns with
conserved cysteines in NifU and have been identified as [Fe-S] ligands, enriched in Ser and
Thr residues (typical of regulatory phosphorylation sites) and required for growth.33 A more
exhaustive sequence analysis of SAV1430, based on the results with SAV0936, indicates the
protein shares ~30% sequence identity with the C-terminal region of the C-terminal domain
of the NifU multidomain structure (Fig. 4). The observed ferredoxin-like fold for SAV1430 is
consistent with the electron transfer activity in the [Fe-S] cluster assembly pathway.34 But,
the lack of any cysteine residues in the SAV1430 sequence and an inability to bind iron indicate
SAV1430 would not play a direct role in the electron transfer activity. SAV1430 and SAV0936
sequences account for the majority of the full length NifU domain. These results imply that
SAV1430 would interact with SAV0936 to form a complex that exhibits similar activity as the
full length NifU domain.
The apparent requirement for prokaryotic SAV1430 to form a protein-protein complex, instead
of an intact single domain observed in eukaryotic organisms, may suggest a protein assembly
or regulation mechanism for SAV1430 in S. aureus. The proper assembly of the SAV1430-
SAV0936 complex may be required for activity of the NifU-like domain or to provide a
mechanism to regulate the [Fe-S] cluster assembly pathway. Potentially, phosphorylation of
SAV0936 in the CXXC loop motif may regulate the SAV1430-SAV0936 complex formation
in a manner similar to SH2 domains. Precedence for staphylococcus utilizing heterodimeric
proteins to accomplish what other bacteria accomplish using monomeric proteins can be found
in the enzyme serine dehydratase. In most bacteria, a single gene encodes the serine
Mercier et al. Page 7













dehydratase; however, in staphylococci two genes (sdhA and sdhB) encode serine dehydratase.
35
Conclusion
Our analysis of hypothetical S. aureus protein SAV1430 in the FAST-NMR screen suggests
SAV1430 is part of a multi-protein complex within the [Fe-S] cluster assembly network, where
SAV1430 may interact with SAV0936 to form a complex that exhibits similar activity as the
intact C-terminus domain of NifU. Formation of the SAV1430-SAV0936 complex may be
regulated in a manner similar to SH2 domains through the phosphorylation of SAV0936. It is
also plausible that the SAV1430-SAV0936 complex may be used to regulate the [Fe-S] cluster
assembly network. It is important to stress that the only information available for hypothetical
protein SAV1430 at the beginning of the FAST-NMR screen was a novel fold and a sequence
similar to other hypothetical proteins. Although the results of the FAST-NMR screen are not
definitive, it provides important direction for further exploration of the biological function of
SAV1430, SAV0936 and other similar hypothetical proteins. The success of structural
genomics has resulted in hundreds of unannotated protein structures being deposited in the
PDB. Inevitably, the inherent value of data generated by genomics sequencing and structural
efforts is significantly reduced without new methodologies to provide annotation information.
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Functional information for hypothetical proteins accumulated from the literature can be
classified into four general categories. Functional identification was obtained for ~40% of the
proteins where ligand binding played a key role.
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Flow Chart for the FAST-NMR screen.
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FAST-NMR analysis of SAV1430. Example of 1D NMR line-broadening spectra obtained in
the SAV1430 screen. Expanded NMR region corresponding to the aromatic residues (a) in the
presence of SAV1430 and (b) the free mixture, illustrating the binding of SAV1430 by changes
in observed NMR line-widths. SAV1430 surface where residues that incur a chemical shift
change are darkened. (c) Chemical structure of O-phospho-l-tyrosine shown to bind SAV1430.
(d) Illustration of the use of the NMR defined ligand binding site to direct a protein-ligand co-
structure determination with AutoDock36. (e) GRASP37 electropotential surface where
positive and negative regions are blue and red, respectively. (f) NMR-based ligand-defined
SAV1430 binding site where residues that incur a chemical shift change upon binding
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phosphotyrosine are colored blue. (g) Mapping of functionally conserved residues (colored
blue) identified by ConSurf 38 on the SAV1430 surface. (h) Molecular model of SAV1430-
SE0630 (structural homolog of SAV0936) complex determined by Hex39. SE0630 is shown
as a ribbon. Sequence and structural alignment of (i) SAV1430-pTyr binding site to the (j) Src
SH2 domain’s phosphotyrosine peptide binding site (PDB ID: 1004). The sequence alignment
is shown below the structure where the aligned residues are colored blue.
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(a) Cartoon illustration of the NifU domain structure and the sequence overlap with SAV1430
and SAV0936. (b) Sequence alignment of the C-terminal NifU domain from Brucella
melitensis with SAV1430 (30% identity) and SAV0936 (47% identity).
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